Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Itraconazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 2 1
mAb 4A8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021 7 1
Breast milk Potential treatment - pre-clinical evidence Natural product Antiviral Mar/01/2021 4 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 14
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 6 1
Low Molecular Weight Heparin Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/18/2021 6 1
Maduramicin Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 2 0
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 10 1